Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chun Chieh Lin, PhD, MBA, Matthew P

Published byDaniella Watkins Modified over 5 years ago

Similar presentations

Presentation on theme: "Chun Chieh Lin, PhD, MBA, Matthew P"— Presentation transcript:

1 Risk-Adjusted Margin Positivity Rate as a Surgical Quality Metric for Non-Small Cell Lung Cancer 
Chun Chieh Lin, PhD, MBA, Matthew P. Smeltzer, MStat, PhD, Ahmedin Jemal, DVM, PhD, Raymond U. Osarogiagbon, MBBS  The Annals of Thoracic Surgery  Volume 104, Issue 4, Pages (October 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Patient selection schema. (NSCLC = non-small cell lung cancer.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Margin-positive rate by stage.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier survival curves by facility performance category: underperforming (blue); nonoutlier (red); and outperforming (green). Crosses indicate censored; log rank p less than The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Chun Chieh Lin, PhD, MBA, Matthew P"

Similar presentations

Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Benny Weksler, MD, Jennifer L. Sullivan, MD 

Benny Weksler, MD, Jennifer L. Sullivan, MD 
Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D

Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Long Interspersed Nucleotide Element 1 Hypomethylation Is Associated With Poor Prognosis of Lung Adenocarcinoma  Koei Ikeda, MD, PhD, Kenji Shiraishi,

Long Interspersed Nucleotide Element 1 Hypomethylation Is Associated With Poor Prognosis of Lung Adenocarcinoma  Koei Ikeda, MD, PhD, Kenji Shiraishi,
Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Feasibility and Safety of Nonintubated Thoracoscopic Lobectomy for Geriatric Lung Cancer Patients  Chun-Yu Wu, MD, Jin-Shing Chen, MD, PhD, Yi-Shiuan.

Feasibility and Safety of Nonintubated Thoracoscopic Lobectomy for Geriatric Lung Cancer Patients  Chun-Yu Wu, MD, Jin-Shing Chen, MD, PhD, Yi-Shiuan.
Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,
B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A

B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Similar presentations

Ads by Google